Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cachexia-Anorexia Syndrome × selpercatinib × 90 days × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Thyroid Neoplasms 2 Sarcoma 2 Central Nervous System Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Thyroid Diseases 1 Thyroid Cancer, Papillary 1 Thoracic Neoplasms 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms by Site 1 Neoplasms 1 Myofibromatosis 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Lung Diseases 1 Histiocytosis, Langerhans-Cell 1 Histiocytic Sarcoma 1 Hepatoblastoma 1 Head and Neck Neoplasms 1 Glioma 1 Ependymoma 1

Interventions

selpercatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07146893 2026-01-15

FEATHER

University of Oklahoma

Phase EARLY_PHASE1 Not yet recruiting

Cachexia-Anorexia Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡